All recalls
Every recall from CPSC, FDA, USDA and NHTSA, newest first. Each one links to the agency's official notice. Looking for one product? Check a product.
22,260 recalls · page 371 of 446
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ampicillin with Sulbactam 10/10 ¿gThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Augmentin - 3¿gThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Azithromycin -15 ¿gThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Aztreonam - 30 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefaclor - 30 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefepime - 30 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefixime - 5 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefotaxime - 30 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefpodoxime - 10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ceftaroline - 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ceftazidime- 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ceftriaxone- 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefuroxime- 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Chloramphenicol- 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ciprofloxacin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Clarithromycin- 15 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Doripenem- 15 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ertapenem- 10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Imipenem- 10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Levofloxacin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Meropenem- 10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Minocycline - 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Moxifloxacin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ofloxacin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Rifampin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Tetracycline 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Microbiologics Inc recalls Microbiologics Enteric Pathogens Control Panel (Inactivated Pellet)The negative control was contaminated with one of the positive control pathogens (Norovirus). This would result in users getting a positive call for Norovirus when running the negative control.
-
Mediumest. risk
Forest River, Inc.: Battery Boost Wiring May Short CircuitA loss of power steering increases the risk of a crash.
-
Highest. risk
E-One Incorporated: Overloaded Electrical System May Cause FireOverloaded electrical circuits can overheat, increasing the risk of fire.
-
Mediumest. risk
Marion Body Works Inc.: Delay in Park Brake Engagement/FMVSS 121Unintentional vehicle movement can increase the risk of a crash or injury.
-
Class Iofficial
World Green Nutrition Inc. recalls ELV ALIPOTEC brand MEXICAN TEJOCOTE ROOT SUPPLEMENT PIECES (RAIZ DE TEJOCOTE MEXICANO SUPLEMENTO EN TROZOS)FDA analysis found product labeled as tejocote is actually contains yellow oleander, which is toxic to humans.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP 150mgSubpotent Drug and Failed Impurities/Degradation Specifications
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP 300mgSubpotent Drug and Failed Impurities/Degradation Specifications
-
Class IIofficial
DeIorio Foods, Inc. recalls DeIorio FoodsProduct contains conveyor belt pieces.
-
Class IIofficial
Impulse Dynamics (usa) Inc recalls OPTIMIZER model CCM X11 implantable pulse generator (IPG) devices - Smart Mini and LiteOPTIMIZER devices may cease to deliver CCM therapy if the device incorrectly detects a charging error. This may cause patients to experience heart failure symptoms similar to before implantation of the device.
-
Class IIofficial
Olympus Corporation of the Americas recalls Hemostasis ProbeThe BICOAG Hemostasis Probe with a coaxial plug was mispackaged into the package and labeled as a BICOAG Hemostasis Probe with a fixed pin connector.
-
Mediumest. risk
Forest River, Inc.: Draw Bar Locking Mechanism May BreakA trailer that contacts the road during transit increases the risk of a crash or injury.
-
Highest. risk
Mickey Truck Bodies, Inc.: Exposed Wiring May Cause FireElectrical arcing can increase the risk of a fire.
-
Mediumest. risk
H.H. Brown Shoe Company Recalls Redeemer Work Boots Due to Injury HazardThe sole is not puncture-resistant, posing an injury hazard.
-
Mediumest. risk
Bell Sports Recalls Bell Slope Adult Bicycle Helmets Due to Risk of Head InjuryThe strap anchor can become dislodged from the helmet when sufficient force is applied, and therefore violates the CPSC federal safety regulation for bicycle helmets. The helmets can fail to protect in the event of a crash, posing a risk of head injury.
-
Mediumest. risk
Ride Aventon Recalls Sinch.2 Folding E-Bicycles Due to Crash and Injury HazardsThe recalled e-bikes can accelerate unexpectedly, resulting in loss of control, posing crash and injury hazards.
-
Highest. risk
Homedics Recalls Massagers Due to Fire and Burn HazardsThe massagers can overheat while charging, posing fire and burn hazards.
-
Highest. risk
UBBCARE Play Yard Mattresses Recalled Due to Suffocation Hazard for Infants; Violation of the Federal Safety Regulation for Crib Mattresses; Sold Exclusively on Amazon.com by UBBCAREThe recalled play yard mattresses violate multiple provisions of the federal safety regulation for crib mattresses, including the thickness test, and are missing warnings and labels. The product poses a suffocation hazard to infants.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Fluocinolone Acetonide OilFailed Excipient Specifications: OOS for assay of Isopropyl Alcohol
-
Class Iofficial
Azurity Pharmaceuticals, Inc. recalls Zenzedi (Dextroamphetamine Sulfate) CII TabletsLabeling: Label Mix-up
-
Class IIofficial
Ventura Foods Llc recalls DELI CAROLINA STYLE MUSTARD BBQ SAUCEUndeclared fish (anchovy) allergen
-
Class IIofficial
Lidl US TRADING recalls Duc De Coeur Camembert Cheese Croquettes Frozen NET WT 9 OZ (256g) UPC 2023 8391 Packaged in a cardboard cartoPossible contamination with Listeria monocytogenes
-
Class Iofficial
U.S. Tov, Inc. recalls Dragonfly Jelly Bar Handbag 11.64ozPotential choking hazard; product contains konjac.